Normal view MARC view ISBD view

Unbalanced Peptidergic Inhibition in Superficial Neocortex Underlies Spike and Wave Seizure Activity. [electronic resource]

By:

Hall, S

Contributor(s):

Producer: 20150908Description: 9302-14 p. digitalISSN:

1529-2401

Subject(s):

Online resources:

Available from publisher's website

In: The Journal of neuroscience : the official journal of the Society for Neuroscience vol. 35

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

9521 Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm.
by Swerdlow, Neal R
9522 Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
by Swerdlow, Neal R
9523 Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
by Reneman, L
9524 Habituation to test procedure modulates the involvement of dopamine D2- but not D1-receptors in ethanol-induced locomotor stimulation in mice.
by Pastor, Raúl
9525 Obesity susceptibility CART gene polymorphism contributes to bone remodeling in postmenopausal women.
by Guérardel, Audrey
9526 Explanations for methamphetamine use among gay and bisexual men in New York City.
by Halkitis, Perry N
9527 Mossy cells and different subpopulations of pyramidal neurons are immunoreactive for cocaine- and amphetamine-regulated transcript peptide in the hippocampal formation of non-human primates and tree shrew (Tupaia belangeri).
by Abrahám, H
9528 Ecstasy and the concomitant use of pharmaceuticals.
by Copeland, Jan
9529 Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
by Gentry, W Brooks
9530 Trace amine-associated receptor 1 modulates dopaminergic activity.
by Lindemann, Lothar
9531 Reduced palatability in lithium- and activity-based, but not in amphetamine-based, taste aversion learning.
by Dwyer, Dominic M
9532 Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case.
by Goodchild, Jason H
9533 Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
by Marinelli-Casey, Patricia
9534 Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons.
by Wiltschko, Alexander B
9535 Methamphetamine use and criminal behavior.
by Gizzi, Michael C
9536 Topiramate in the treatment of substance-related disorders: a critical review of the literature.
by Shinn, Ann K
9537 CE assay for simultaneous determination of charged and neutral impurities in dexamphetamine sulfate using a dual CD system.
by Wongwan, Sudaporn
9538 The rise of methamphetamine in Southeast and East Asia.
by McKetin, Rebecca
9539 The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.
by Thiemann, Gunnar
9540 Methamphetamine ("tik") use and its association with condom use among out-of-school females in Cape Town, South Africa.
by Wechsberg, Wendee M